BIOCONNSEBiocon Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 21 Jan · 20:12 IST

Biocon Limited has informed the Exchange regarding 'Certificate pursuant to SEBI Master Circular no. SEBI/HO/DDHS/DDHSPoD/P/CIR/2025/0000000137 dated October 15, 2025'.

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Biocon Limited has submitted a certificate to the National Stock Exchange as required under SEBI Master Circular no. SEBI/HO/DDHS/DDHSPoD/P/CIR/2025/0000000137 dated October 15, 2025. This circular is issued by SEBI's Department of Debt and Hybrid Securities (DDHS) and governs disclosure and compliance requirements for listed debt securities. The filing indicates that Biocon, which has listed non-convertible debt instruments, has met its periodic compliance obligation under the new master circular framework. No specific financial numbers or material business update are disclosed in this filing.

Likely market impact

This is a routine regulatory compliance filing with no direct material impact on shareholders or stock price. It confirms Biocon is up to date with its debt-related disclosure obligations under SEBI's revised framework effective from late 2025.